Glenmark Life Sciences Ltd Q3 FY2022-23 PAT slips to Rs. 104.99 crores

The Board of Directors of Glenmark Life Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

Related Keywords

,Glenmark Life Sciences Ltd ,Life Sciences Ltd ,Glenmarklifesciences ,Q3fy23 ,9mfy23 ,Resultupdate ,